Search

Your search keyword '"Benassi, Alberto"' showing total 50 results
Start Over Author "Benassi, Alberto"
50 results on '"Benassi, Alberto"'

1. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)

Author

Godino, Cosmo, Beneduce, Alessandro, Ferrante, Giuseppe, Ielasi, Alfonso, Pivato, Carlo Andrea, Chiarito, Mauro, Cappelletti, Alberto, Perfetti, Giulia, Magni, Valeria, Prati, Eugenio, Falcone, Stefania, Pierri, Adele, De Martini, Stefano, Montorfano, Matteo, Parisi, Rosario, Rutigliano, David, Locuratolo, Nicola, Anzuini, Angelo, Tespilli, Maurizio, Margonato, Alberto, Benassi, Alberto, Briguori, Carlo, Fabbiocchi, Franco, Reimers, Bernhard, Bartorelli, Antonio, and Colombo, Antonio

Published
2018
Full Text
View/download PDF

2. [SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention]

Author

Guarini, Pasquale, Saia, Francesco, Sidiropulos, Milena, Silverio, Angelo, Dellegrottaglie, Santo, Scatteia, Alessandra, De Stefano, Francesco, Tedeschi, Carlo, Dalla Vecchia, Laura A., Cappelletti, Alberto M., Regazzoli, Damiano, Benassi, Alberto, Donatelli, Francesco, America, Raffaella, Nosso, Gabriella, Capranzano, Piera, Oliva, Angelo, Piccolo, Raffaele, Testa, Luca, Attisano, Tiziana, Battistina, Castiglioni, Contarini, Marco, De Marco, Federico, Fineschi, Massimo, Menozzi, Alberto, Musto, Carmine, Stefanini, Giulio, Tarantini, Giuseppe, Caiazza, Francesco, and Esposito, Giovanni

Published
2023

3. Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study

Author

De Stefano, Francesco, Benassi, Alberto, Cappelletti, Alberto Maria, Donatelli, Francesco, Regazzoli, Damiano, Tolaro, Salvatore, Perego, Francesca, Silverio, Angelo, Scatteia, Alessandra, Guarini, Pasquale, Dellegrottaglie, Santo, Mariani, Simona, Pezzella, Elpidio, Galasso, Gennaro, Caiazza, Francesco, and On Behalf Of Isnep Investigators, Null

Subjects
vitamin K antagonists, Medicine (miscellaneous), atrial fibrillation, elderly, non-vitamin k antagonist oral anticoagulants, Settore MED/11 - Malattie dell'Apparato Cardiovascolare, Settore MED/23 - Chirurgia Cardiaca
Abstract

Background: Atrial fibrillation (AF) is the most common heart arrhythmia, and its prevalence increases with age. Oral Anticoagulant Therapy (OAT) with non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) is essential to avoid thromboembolic events in AF. However, this treatment is associated with a high risk of bleeding and low adherence in elderly patients. Aim: The aim was to evaluate the real-world use of OAT in a population of patients aged ≥80 years in twenty-three Italian centers and to investigate the tolerance of and patient satisfaction with this therapy. Methods: The ISNEP Study is a multicenter cross-sectional study enrolling patients with AF and aged ≥80 years and treated with either NOACs or VKAs. A written questionnaire was administered to each patient to evaluate the adherence to and patient satisfaction with this therapy. Results: The study included 641 patients with a mean age of 85 (82–87) years. The use of NOACs was reported in 93.0% of cases, with the remaining 7.0% treated with VKAs. A history of stroke events was reported in five (11.1%) and one (0.2%) patients in the VKA and NOAC groups, respectively. The rate of referred ecchymosis/epistaxis was significantly higher in the VKA group compared to the NOAC group (p < 0.001). Patients receiving NOACs reported a substantial improvement in their quality of life compared to the VKA group. Conclusions: A small, but not negligible, proportion of elderly AF patients is still treated with VKAs. Patients treated with NOAC have a higher level of satisfaction with the therapy and complete adherence.

Published
2022

5. Transradial Versus Transfemoral Intervention for Acute Myocardial Infarction: A Propensity Score-Adjusted and -Matched Analysis From the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) Multicenter Registry

Author

Valgimigli, Marco, Saia, Francesco, Guastaroba, Paolo, Menozzi, Alberto, Magnavacchi, Paolo, Santarelli, Andrea, Passerini, Francesco, Sangiorgio, Pietro, Manari, Antonio, Tarantino, Fabio, Margheri, Massimo, Benassi, Alberto, Sangiorgi, Massimo Giuseppe, Tondi, Stefano, and Marzocchi, Antonio

Published
2012
Full Text
View/download PDF

7. Impact of Acute Coronary Syndromes on Two-Year Clinical Outcomes in Patients With Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents

Author

Palmerini, Tullio, Sangiorgi, Diego, Marzocchi, Antonio, Tamburino, Corrado, Sheiban, Imad, Margheri, Massimo, Vecchi, Giuseppe, Sangiorgi, Giuseppe, Franco, Nicoletta, Bartorelli, Antonio, Briguori, Carlo, Vignali, Luigi, Di Pede, Francesco, Ramondo, Angelo, Medda, Massimo, De Carlo, Marco, Bolognese, Leonardo, Benassi, Alberto, Palmieri, Cataldo, Filippone, Vincenzo, Lauria, Giulia, and De Servi, Stefano

Published
2010
Full Text
View/download PDF

8. Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: Results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS)

Author

Romagnoli, Enrico, De Servi, Stefano, Tamburino, Corrado, Colombo, Antonio, Burzotta, Francesco, Presbitero, Patrizia, Bolognese, Leonardo, Paloscia, Leonardo, Rubino, Paolo, Sardella, Gennaro, Briguori, Carlo, Ettori, Federica, Franco, Gianfranco, Di Girolamo, Domenico, Sheiban, Imad, Piatti, Luigi, Greco, Cesare, Petronio, Sonia, Loi, Bruno, Lioy, Ernesto, Benassi, Alberto, Patti, Aldo, Gaspardone, Achille, Capodanno, Davide, Biondi-Zoccai, Giuseppe G.L., and Sangiorgi, Giuseppe

Published
2010
Full Text
View/download PDF

9. Temporal Pattern of Ischemic Events in Relation to Dual Antiplatelet Therapy in Patients With Unprotected Left Main Coronary Artery Stenosis Undergoing Percutaneous Coronary Intervention

Author

Palmerini, Tullio, Marzocchi, Antonio, Tamburino, Corrado, Sheiban, Imad, Margheri, Massimo, Vecchi, Giuseppe, Sangiorgi, Giuseppe, Santarelli, Andrea, Bartorelli, Antonio L., Briguori, Carlo, Vignali, Luigi, Di Pede, Francesco, Ramondo, Angelo, Inglese, Luigi, De Carlo, Marco, Bolognese, Leonardo, Benassi, Alberto, Palmieri, Cataldo, Filippone, Vincenzo, Sangiorgi, Diego, Barlocco, Fabio, Lauria, Giulia, and De Servi, Stefano

Published
2009
Full Text
View/download PDF

10. Comparison of Drug-Eluting Stents and Bare-Metal Stents for the Treatment of Unprotected Left Main Coronary Artery Disease in Acute Coronary Syndromes

Author

Tamburino, Corrado, Di Salvo, Maria Elena, Capodanno, Davide, Palmerini, Tullio, Sheiban, Imad, Margheri, Massimo, Vecchi, Giuseppe, Sangiorgi, Giuseppe, Piovaccari, Giancarlo, Bartorelli, Antonio, Briguori, Carlo, Ardissino, Diego, Di Pede, Francesco, Ramondo, Angelo, Inglese, Luigi, Petronio, Anna Sonia, Bolognese, Leonardo, Benassi, Alberto, Palmieri, Cataldo, Filippone, Vincenzo, and De Servi, Stefano

Published
2009
Full Text
View/download PDF

11. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients

Author

Biondi-Zoccai, Giuseppe, Sheiban, Imad, Moretti, Claudio, Palmerini, Tullio, Marzocchi, Antonio, Capodanno, Davide, Tamburino, Corrado, Margheri, Massimo, Vecchi, Giuseppe, Sangiorgi, Giuseppe, Santarelli, Andrea, Bartorelli, Antonio l., Briguori, Carlo, Vignali, Luigi, Pede, Francesco di, Ramondo, Angelo, Medda, Massimo, de Carlo, Marco, Falsini, Giovanni, Benassi, Alberto, Palmieri, Cataldo, Filippone, Vincenzo, Sangiorgi, Diego, Barlocco, Fabio, and de Servi, Stefano

Published
2011
Full Text
View/download PDF

12. Two-Year Clinical Outcome With Drug-Eluting Stents Versus Bare-Metal Stents in a Real-World Registry of Unprotected Left Main Coronary Artery Stenosis from the Italian Society of Invasive Cardiology

Author

Palmerini, Tullio, Marzocchi, Antonio, Tamburino, Corrado, Sheiban, Imad, Margheri, Massimo, Vecchi, Giuseppe, Sangiorgi, Giuseppe, Santarelli, Andrea, Bartorelli, Antonio, Briguori, Carlo, Vignali, Luigi, Di Pede, Francesco, Ramondo, Angelo, Inglese, Luigi, De Carlo, Marco, Bolognese, Leonardo, Benassi, Alberto, Palmieri, Cataldo, Filippone, Vincenzo, Sangiorgi, Diego, and De Servi, Stefano

Published
2008
Full Text
View/download PDF

13. Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry)

Author

Vignali, Luigi, Saia, Francesco, Manari, Antonio, Santarelli, Andrea, Rubboli, Andrea, Varani, Elisabetta, Piovaccari, Giancarlo, Menozzi, Alberto, Percoco, Gianfranco, Benassi, Alberto, Rusticali, Guido, Marzaroli, Paolo, Guastaroba, Paolo, Grilli, Roberto, Maresta, Aleardo, and Marzocchi, Antonio

Published
2008
Full Text
View/download PDF

17. One‐year clinical outcome of biodegradable polymer sirolimus‐eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)

Author

Beneduce, Alessandro, primary, Ferrante, Giuseppe, additional, Ielasi, Alfonso, additional, Pivato, Carlo A., additional, Chiarito, Mauro, additional, Cappelletti, Alberto, additional, Baldetti, Luca, additional, Magni, Valeria, additional, Prati, Eugenio, additional, Falcone, Stefania, additional, Pierri, Adele, additional, De Martini, Stefano, additional, Montorfano, Matteo, additional, Parisi, Rosario, additional, Rutigliano, David, additional, Locuratolo, Nicola, additional, Anzuini, Angelo, additional, Tespili, Maurizio, additional, Margonato, Alberto, additional, Benassi, Alberto, additional, Briguori, Carlo, additional, Reimers, Bernhard, additional, Fabbiocchi, Franco, additional, Bartorelli, Antonio, additional, Colombo, Antonio, additional, and Godino, Cosmo, additional

Published
2020
Full Text
View/download PDF

18. [Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation]

Author

Tarantini, Giuseppe, Esposito, Giovanni, Musumeci, Giuseppe, Fraccaro, Chiara, Franzone, Anna, Castiglioni, Battistina, La Manna, Alessio, Limbruno, Ugo, Marchese, Alfredo, Mauro, Ciro, Rigattieri, Stefano, Tarantino, Fabio, Gandolfo, Caterina, Santoro, Gennaro, Violini, Roberto, Airoldi, Flavio, Albiero, Remo, Balbi, Manrico, Baralis, Giorgio, Bartorelli, Antonio Luca, Bedogni, Francesco, Benassi, Alberto, Berni, Andrea, Bonzani, Giulio, Bortone, Alessandro Santo, Braito, Giuseppe, Briguori, Carlo, Brscic, Elvis, Calabrò, Paolo, Calchera, Ivan, Cappelli Bigazzi, Maurizio, Caprioglio, Francesco, Castriota, Fausto, Cernetti, Carlo, Cicala, Cinzia, Cioffi, Paolo, Colombo, Antonio, Colombo, Virgilio, Contegiacomo, Gaetano, Cremonesi, Alberto, D'Amico, Maurizio, De Benedictis, Mauro, De Leo, Alessandro, Di Biasi, Maurizio, Di Girolamo, Domenico, Di Lorenzo, Emilio, Di Mario, Carlo, Dominici, Marcello, Ettori, Federica, Ferrario, Maurizio, Fioranelli, Massimo, Fischetti, Dionigi, Gabrielli, Gabriele, Giordano, Arturo, Giudice, Pietro, Greco, Cesare, Indolfi, Ciro, Leonzi, Ornella, Lettieri, Corrado, Loi, Bruno, Maddestra, Nicola, Marchionni, Niccolò, Marrozzini, Cinzia, Medda, Massimo, Missiroli, Bindo, My, Luigi, Oreglia, Jacopo Andrea, Palmieri, Cataldo, Pantaleo, Paolo, Paparoni, Saro Roberto, Parodi, Guido, Petronio, Anna Sonia, Piatti, Luigi, Piccaluga, Emanuela, Pierli, Carlo, Perkan, Andrea, Pitì, Antonino, Poli, Arnaldo, Ramondo, Angelo Bruno, Reale, Maurizio Alessandro, Reimers, Bernhard, Ribichini, Flavio Luciano, Rosso, Roberta, Saccà, Salvatore, Sacra, Cosimo, Santarelli, Andrea, Sardella, Gennaro, Satullo, Gaetano, Scalise, Filippo, Siviglia, Massimo, Spedicato, Leonardo, Stabile, Amerigo, Tamburino, Corrado, Tesorio, Tullio Nicola Maria, Tolaro, Salvatore, Tomai, Fabrizio, Trani, Carlo, Valenti, Renato, Valsecchi, Orazio, Valva, Giuseppe, Varbella, Ferdinando, Vigna, Carlo, Vignali, Luigi, Berti, Sergio, Tarantini, Giuseppe, Esposito, Giovanni, Musumeci, Giuseppe, Fraccaro, Chiara, Franzone, Anna, Castiglioni, Battistina, La Manna, Alessio, Limbruno, Ugo, Marchese, Alfredo, Mauro, Ciro, Rigattieri, Stefano, Tarantino, Fabio, Gandolfo, Caterina, Santoro, Gennaro, Violini, Roberto, Airoldi, Flavio, Albiero, Remo, Balbi, Manrico, Baralis, Giorgio, Bartorelli, Antonio Luca, Bedogni, Francesco, Benassi, Alberto, Berni, Andrea, Bonzani, Giulio, Bortone, Alessandro Santo, Braito, Giuseppe, Briguori, Carlo, Brscic, Elvi, Calabrò, Paolo, Calchera, Ivan, Cappelli Bigazzi, Maurizio, Caprioglio, Francesco, Castriota, Fausto, Cernetti, Carlo, Cicala, Cinzia, Cioffi, Paolo, Colombo, Antonio, Colombo, Virgilio, Contegiacomo, Gaetano, Cremonesi, Alberto, D'Amico, Maurizio, De Benedictis, Mauro, De Leo, Alessandro, Di Biasi, Maurizio, Di Girolamo, Domenico, Di Lorenzo, Emilio, Di Mario, Carlo, Dominici, Marcello, Ettori, Federica, Ferrario, Maurizio, Fioranelli, Massimo, Fischetti, Dionigi, Gabrielli, Gabriele, Giordano, Arturo, Giudice, Pietro, Greco, Cesare, Indolfi, Ciro, Leonzi, Ornella, Lettieri, Corrado, Loi, Bruno, Maddestra, Nicola, Marchionni, Niccolò, Marrozzini, Cinzia, Medda, Massimo, Missiroli, Bindo, My, Luigi, Oreglia, Jacopo Andrea, Palmieri, Cataldo, Pantaleo, Paolo, Paparoni, Saro Roberto, Parodi, Guido, Petronio, Anna Sonia, Piatti, Luigi, Piccaluga, Emanuela, Pierli, Carlo, Perkan, Andrea, Pitì, Antonino, Poli, Arnaldo, Ramondo, Angelo Bruno, Reale, Maurizio Alessandro, Reimers, Bernhard, Ribichini, Flavio Luciano, Rosso, Roberta, Saccà, Salvatore, Sacra, Cosimo, Santarelli, Andrea, Sardella, Gennaro, Satullo, Gaetano, Scalise, Filippo, Siviglia, Massimo, Spedicato, Leonardo, Stabile, Amerigo, Tamburino, Corrado, Tesorio, Tullio Nicola Maria, Tolaro, Salvatore, Tomai, Fabrizio, Trani, Carlo, Valenti, Renato, Valsecchi, Orazio, Valva, Giuseppe, Varbella, Ferdinando, Vigna, Carlo, Vignali, Luigi, and Berti, Sergio

Subjects
Transcatheter aortic valve implantation, Transcatheter aortic valve implantation, TAVI, severe aortic stenosis, Operators, Biomedical Technology, Requirements, Aortic Valve Stenosis, Institutions, Severity of Illness Index, Transcatheter Aortic Valve Replacement, TAVI, Italy, Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE, Training, Humans, Program Development, severe aortic stenosis
Abstract

Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis and has become the standard of care for inoperable patients and the preferred therapy for those at increased surgical risk with peculiar clinical and anatomic features. Technology advances, growing experience and accumulating data prompted the update of the 2011 Italian Society of Interventional Cardiology (SICI-GISE) position paper on institutional and operator requirements to perform TAVI. The main objective of this document is to provide a guidance to assess the potential of institutions and operators to initiate and maintain an efficient TAVI program.

Published
2018

19. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology

Author

Palmerini, Tullio, Sangiorgi, Diego, Marzocchi, Antonio, Tamburino, Corrado, Sheiban, Imad, Margheri, Massimo, Vecchi, Giuseppe, Sangiorgi, Giuseppe, Ruffini, Michele, Bartorelli, Antonio L., Briguori, Carlo, Vignali, Luigi, Di Pede, Francesco, Ramondo, Angelo, Inglese, Luigi, De Carlo, Marco, Bolognese, Leonardo, Benassi, Alberto, Palmieri, Cataldo, Filippone, Vincenzo, Barlocco, Fabio, Lauria, Giulia, and De Servi, Stefano

Published
2009

20. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry

Author

Tamburino, Corrado, Di Salvo, Maria Elena, Capodanno, Davide, Marzocchi, Antonio, Sheiban, Imad, Margheri, Massimo, Maresta, Aleardo, Barlocco, Fabio, Sangiorgi, Giuseppe, Piovaccari, Giancarlo, Bartorelli, Antonio, Briguori, Carlo, Ardissino, Diego, Di Pede, Francesco, Ramondo, Angelo, Inglese, Luigi, Petronio, Anna Sonia, Bolognese, Leonardo, Benassi, Alberto, Palmieri, Cataldo, Patti, Aldo, and De Servi, Stefano

Published
2009

21. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: Results from a real-world multicenter registry

Author

Capodanno, Davide, Di Salvo, Maria Elena, Palmerini, Tullio, Sheiban, Imad, Margheri, Massimo, Vecchi, Giuseppe, Sangiorgi, Giuseppe, Piovaccari, Giancarlo, Bartorelli, Antonio, Briguori, Carlo, Ardissino, Diego, Di Pede, Francesco, Ramondo, Angelo, Inglese, Luigi, Petronio, Anna Sonia, Bolognese, Leonardo, Benassi, Alberto, Palmieri, Cataldo, Filippone, Vincenzo, De Servi, Stefano, and Tamburino, Corrado

Published
2009
Full Text
View/download PDF

26. Proximal Endovascular Flow Blockage for Cerebral Protection During Carotid Artery Stenting: Results From a Prospective Multicenter Registry

Author

Reimers, Bernhard, Sievert, Horst, Schuler, Gerhard C., Tübler, Thilo, Diederich, Klaus, Schmidt, Andrej, Rubino, Paolo, Mudra, Harald, Dudek, Dariusz, Coppi, Gioacchino, Schofer, Joachim, Cremonesi, Alberto, Haufe, Mathias, Resta, Maurizio, Klauss, Volker, Benassi, Alberto, Di Mario, Carlo, Favero, Luca, Scheinert, Dierk, Salemme, Luigi, and Biamino, Giancarlo

Published
2005

27. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients needing short dual antiplatelet therapy. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)

Author

Godino, Cosmo, primary, Beneduce, Alessandro, additional, Ferrante, Giuseppe, additional, Ielasi, Alfonso, additional, Pivato, Carlo Andrea, additional, Chiarito, Mauro, additional, Cappelletti, Alberto, additional, Perfetti, Giulia, additional, Magni, Valeria, additional, Prati, Eugenio, additional, Falcone, Stefania, additional, Pierri, Adele, additional, De Martini, Stefano, additional, Montorfano, Matteo, additional, Parisi, Rosario, additional, Rutigliano, David, additional, Locuratolo, Nicola, additional, Anzuini, Angelo, additional, Tespili, Maurizio, additional, Margonato, Alberto, additional, Benassi, Alberto, additional, Briguori, Carlo, additional, Fabbiocchi, Franco, additional, Reimers, Bernhard, additional, Bartorelli, Antonio, additional, and Colombo, Antonio, additional

Published
2019
Full Text
View/download PDF

28. One‐year clinical outcome of biodegradable polymer sirolimus‐eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry

Author

Moscarella, Elisabetta, primary, Ielasi, Alfonso, additional, Beneduce, Alessandro, additional, Ferrante, Giuseppe, additional, Pivato, Carlo Andrea, additional, Chiarito, Mauro, additional, Cappelletti, Alberto, additional, Perfetti, Giulia, additional, Magni, Valeria, additional, Prati, Eugenio, additional, Falcone, Stefania, additional, Pierri, Adele, additional, De Martini, Stefano, additional, Montorfano, Matteo, additional, Parisi, Rosario, additional, Rutigliano, David, additional, Locuratolo, Nicola, additional, Anzuini, Angelo, additional, Calabrò, Paolo, additional, Tespili, Maurizio, additional, Margonato, Alberto, additional, Benassi, Alberto, additional, Briguori, Carlo, additional, Fabbiocchi, Franco, additional, Reimers, Bernhard, additional, Bartorelli, Antonio, additional, Colombo, Antonio, additional, and Godino, Cosmo, additional

Published
2019
Full Text
View/download PDF

29. TCT-229 One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comer population of ULISSE registry (ULtimaster Italian multicentre all-comerS Stent rEgistry)

Author

Godino, Cosmo, primary, Beneduce, Alessandro, additional, Pivato, Carlo Andrea, additional, Chiarito, Mauro, additional, Cappelletti, Alberto, additional, Ferrante, Giuseppe, additional, Perfetti, Giulia, additional, Fabbiocchi, Franco, additional, Falcone, Stefania, additional, Ielasi, Alfonso, additional, Pierri, Adele, additional, Magni, Valeria, additional, Montorfano, Matteo, additional, De Martini, Stefano, additional, Parisi, Rosario, additional, Rutigliano, David, additional, Locuratolo, Nicola, additional, Margonato, Alberto, additional, Benassi, Alberto, additional, Anzuini, Angelo, additional, Reimers, Bernhard, additional, Tespilli, Maurizio, additional, Briguori, Carlo, additional, Bartorelli, Antonio, additional, and Colombo, Antonio, additional

Published
2017
Full Text
View/download PDF

30. TCT-249 Clinical Outcomes of Biodegradable Polymer Sirolimus Eluting Stent in Diabetes Mellitus Patients.

Author

Godino, Cosmo, primary, Pivato, Carlo Andrea, additional, Beneduce, Alessandro, additional, Cappelletti, Alberto, additional, Ferrante, Giuseppe, additional, Fabbiocchi, Franco, additional, Falcone, Stefania, additional, Ielasi, Alfonso, additional, Pierri, Adele, additional, Chiarito, Mauro, additional, Magni, Valeria, additional, Perfetti, Giulia, additional, Scotti, Andrea, additional, Montorfano, Matteo, additional, De Martini, Stefano, additional, Parisi, Rosario, additional, Rutigliano, David, additional, Locuratolo, Nicola, additional, Margonato, Alberto, additional, Benassi, Alberto, additional, Anzuini, Angelo, additional, Reimers, Bernhard, additional, Tespilli, Maurizio, additional, Briguori, Carlo, additional, Bartorelli, Antonio, additional, and Colombo, Antonio, additional

Published
2017
Full Text
View/download PDF

31. TCT-469 One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients with acute coronary syndrome. Insight from the ULISSE registry.

Author

Moscarella, Elisabetta, Ielasi, Alfonso, Godino, Cosmo, Ferrante, Giuseppe, Pivato, Carlo Andrea, Chiarito, Mauro, Cappelletti, Alberto, Perfetti, Giulia, Magni, Valeria, Prati, Eugenio, Falcone, Stefania, Pierri, Adele, De Martini, Stefano, Montorfano, Matteo, rosario parisi, Locuratolo, Nicola, Anzuini, Angelo, Margonato, Alberto, Benassi, Alberto, Calabro', Paolo, Briguori, Carlo, Fabbiocchi, Franco, Reimers, Bernhard, Bartorelli, Antonio, and Colombo, Antonio

Published
2018
Full Text
View/download PDF

32. Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients

Author

Roversi, Sara, primary, Biondi-Zoccai, Giuseppe, additional, Romagnoli, Enrico, additional, Sheiban, Imad, additional, De Servi, Stefano, additional, Tamburino, Corrado, additional, Colombo, Antonio, additional, Burzotta, Francesco, additional, Presbitero, Patrizia, additional, Bolognese, Leonardo, additional, Paloscia, Leonardo, additional, Rubino, Paolo, additional, Sardella, Gennaro, additional, Briguori, Carlo, additional, Niccoli, Luigi, additional, Franco, Gianfranco, additional, Di Girolamo, Domenico, additional, Piatti, Luigi, additional, Greco, Cesare, additional, Petronio, Sonia, additional, Loi, Bruno, additional, Lioy, Ernesto, additional, Benassi, Alberto, additional, Patti, Aldo, additional, Gaspardone, Achille, additional, Capodanno, Davide, additional, Modena, Maria Grazia, additional, and Sangiorgi, Giuseppe, additional

Published
2013
Full Text
View/download PDF

33. ARE “NEW GENERATION” DES SUPERIOR TO “OLD GENERATION” DES IN REDUCING ADVERSE CLINICAL OUTCOMES AT LONG–TERM FOLLOW–UP: INSIGHTS FROM REAL (REGISTRO REGIONALE ANGIOPLASTICHE DELL'EMILIA–ROMAGNA) MULTICENTER REGISTRY

Author

Vignali, Luigi, primary, Solinas, Emilia, additional, Guastaroba, Paolo, additional, Saia, Francesco, additional, Varani, Elisabetta, additional, Santarelli, Andrea, additional, Valgimigli, Marco, additional, Rubboli, Andrea, additional, Benassi, Alberto, additional, Manari, Antonio, additional, Cremonesi, Alberto, additional, Mehran, Roxana, additional, Dangas, George, additional, Ardissino, Diego, additional, Marzocchi, Antonio, additional, and Palma, Rossana De, additional

Published
2013
Full Text
View/download PDF

34. Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score

Author

Biondi-Zoccai, Giuseppe, primary, Romagnoli, Enrico, additional, Castagno, Davide, additional, Sheiban, Imad, additional, De Servi, Stefano, additional, Tamburino, Corrado, additional, Colombo, Antonio, additional, Burzotta, Francesco, additional, Presbitero, Patrizia, additional, Bolognese, Leonardo, additional, Paloscia, Leonardo, additional, Rubino, Paolo, additional, Sardella, Gennaro, additional, Briguori, Carlo, additional, Niccoli, Luigi, additional, Franco, Gianfranco, additional, Di Girolamo, Domenico, additional, Piatti, Luigi, additional, Greco, Cesare, additional, Petronio, A. Sonia, additional, Loi, Bruno, additional, Benassi, Alberto, additional, Patti, Aldo, additional, Gaspardone, Achille, additional, Frati, Giacomo, additional, and Sangiorgi, Giuseppe, additional

Published
2012
Full Text
View/download PDF

35. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients

Author

Biondi-Zoccai, Giuseppe, primary, Sheiban, Imad, additional, Moretti, Claudio, additional, Palmerini, Tullio, additional, Marzocchi, Antonio, additional, Capodanno, Davide, additional, Tamburino, Corrado, additional, Margheri, Massimo, additional, Vecchi, Giuseppe, additional, Sangiorgi, Giuseppe, additional, Santarelli, Andrea, additional, Bartorelli, Antonio l., additional, Briguori, Carlo, additional, Vignali, Luigi, additional, Pede, Francesco di, additional, Ramondo, Angelo, additional, Medda, Massimo, additional, de Carlo, Marco, additional, Falsini, Giovanni, additional, Benassi, Alberto, additional, Palmieri, Cataldo, additional, Filippone, Vincenzo, additional, Sangiorgi, Diego, additional, Barlocco, Fabio, additional, and de Servi, Stefano, additional

Published
2010
Full Text
View/download PDF

36. Sex-related differences in patients undergoing percutaneous unprotected left main stenting

Author

Sheiban, Imad, primary, La Spina, Carlo, additional, Cavallero, Erika, additional, Biondi-Zoccai, Giuseppe, additional, Colombo, Francesco, additional, Palmerini, Tullio, additional, Marzocchi, Antonio, additional, Tamburino, Corrado, additional, Margheri, Massimo, additional, Vecchi, Giuseppe, additional, Sangiorgi, Giuseppe, additional, Santarelli, Andrea, additional, Bartorelli, Antonio, additional, Briguori, Carlo, additional, Vignali, Luigi, additional, di Pede, Francesco, additional, Ramondo, Angelo, additional, Fantoni, Cecilia, additional, de Carlo, Marco, additional, Falsini, Giovanni, additional, Benassi, Alberto, additional, Palmieri, Cataldo, additional, Filippone, Vincenzo, additional, Sangiorgi, Diego, additional, and de Servi, Stefano, additional

Published
2010
Full Text
View/download PDF

38. Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry

Author

Saia, Francesco, primary, Piovaccari, Giancarlo, additional, Manari, Antonio, additional, Guastaroba, Paolo, additional, Vignali, Luigi, additional, Varani, Elisabetta, additional, Santarelli, Andrea, additional, Benassi, Alberto, additional, Liso, Armando, additional, Campo, Gianluca, additional, Tondi, Stefano, additional, Tarantino, Fabio, additional, De Palma, Rossana, additional, and Marzocchi, Antonio, additional

Published
2009
Full Text
View/download PDF

39. Impact of Bifurcation Technique on 2-Year Clinical Outcomes in 773 Patients With Distal Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents

Author

Palmerini, Tullio, primary, Marzocchi, Antonio, additional, Tamburino, Corrado, additional, Sheiban, Imad, additional, Margheri, Massimo, additional, Vecchi, Giuseppe, additional, Sangiorgi, Giuseppe, additional, Santarelli, Andrea, additional, Bartorelli, Antonio, additional, Briguori, Carlo, additional, Vignali, Luigi, additional, Di Pede, Francesco, additional, Ramondo, Angelo, additional, Inglese, Luigi, additional, De Carlo, Marco, additional, Falsini, Giovanni, additional, Benassi, Alberto, additional, Palmieri, Cataldo, additional, Filippone, Vincenzo, additional, Sangiorgi, Diego, additional, Barlocco, Fabio, additional, and De Servi, Stefano, additional

Published
2008
Full Text
View/download PDF

40. Long-Term Safety and Efficacy of Drug-Eluting Stents

Author

Marzocchi, Antonio, primary, Saia, Francesco, additional, Piovaccari, Giancarlo, additional, Manari, Antonio, additional, Aurier, Enrico, additional, Benassi, Alberto, additional, Cremonesi, Alberto, additional, Percoco, Gianfranco, additional, Varani, Elisabetta, additional, Magnavacchi, Paolo, additional, Guastaroba, Paolo, additional, Grilli, Roberto, additional, and Maresta, Aleardo, additional

Published
2007
Full Text
View/download PDF

41. Proximal Endovascular Flow Blockage for Cerebral Protection During Carotid Artery Stenting:Results From a Prospective Multicenter Registry

Author

Reimers, Bernhard, primary, Sievert, Horst, additional, Schuler, Gerhard C., additional, Tübler, Thilo, additional, Diederich, Klaus, additional, Schmidt, Andrej, additional, Rubino, Paolo, additional, Mudra, Harald, additional, Dudek, Dariusz, additional, Coppi, Gioacchino, additional, Schofer, Joachim, additional, Cremonesi, Alberto, additional, Haufe, Mathias, additional, Resta, Maurizio, additional, Klauss, Volker, additional, Benassi, Alberto, additional, Di Mario, Carlo, additional, Favero, Luca, additional, Scheinert, Dierk, additional, Salemme, Luigi, additional, and Biamino, Giancarlo, additional

Published
2005
Full Text
View/download PDF

43. Impact of Drug-Eluting Stents and Diabetes Mellitus in Patients With Coronary Bifurcation Lesions

Author

Capodanno, Davide, Tamburino, Corrado, Sangiorgi, Giuseppe M., Romagnoli, Enrico, Colombo, Antonio, Burzotta, Francesco, Gasparini, Gabriele L., Bolognese, Leonardo, Paloscia, Leonardo, Rubino, Paolo, Sardella, Gennaro, Briguori, Carlo, Ettori, Federica, Franco, Gianfranco, Di Girolamo, Domenico, Sheiban, Imad, Piatti, Luigi, Greco, Cesare, Petronio, Anna Sonia, Loi, Bruno, Lyoi, Ernesto, Benassi, Alberto, Patti, Aldo, Gaspardone, Achille, and De Servi, Stefano

Abstract

We investigated the long-term impact of different stent types and diabetes mellitus (DM) in patients undergoing percutaneous coronary intervention (PCI) of bifurcation lesions, based on a large multicenter survey endorsed by the Italian Society of Invasive Cardiology.

Published
2011
Full Text
View/download PDF

44. Clinical Outcomes for Sirolimus-Eluting Stents and Polymer-Coated Paclitaxel-Eluting Stents in Daily Practice Results From a Large Multicenter Registry

Author

Saia, Francesco, Piovaccari, Giancarlo, Manari, Antonio, Santarelli, Andrea, Benassi, Alberto, Aurier, Enrico, Sangiorgio, Pietro, Tarantino, Fabio, Geraci, Giuseppe, Vecchi, Giuseppe, Guastaroba, Paolo, Grilli, Roberto, and Marzocchi, Antonio

Abstract

ObjectivesWe compared the clinical outcome of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in a real-world scenario.BackgroundIn selected patients, SES has been associated with lower late luminal loss than PES. Whether this emerging biological difference could translate into different clinical efficacy in daily practice is presently unknown.MethodsThis analysis included 1,676 consecutive patients with de novo coronary lesions treated solely with drug-eluting stents (SES = 992; PES = 684). All patients were enrolled in a dynamic prospective registry comprising 13 hospitals. We assessed the cumulative incidence of major adverse cardiac events (MACE), defined as death, myocardial infarction (MI), and target vessel revascularization (TVR) during follow-up.ResultsOverall, 29% of the patients had diabetes, 23% had prior MI, and 9% had poor left ventricular function. ST-segment elevation MI was diagnosed at admission in 12%. Multivessel intervention was performed in 16%. At 1-year follow-up, SES was associated with a reduced incidence of MACE (9.2% SES vs. 14.1% PES; p = 0.007) and TVR (5.0% SES vs. 10.0% PES; p = 0.0008) compared to PES. A propensity analysis with many clinical and angiographic variables was carried out to adjust for baseline differences. In this analysis, SES was associated with a 44% risk reduction of MACE (hazard ratio 0.56, 95% confidence interval 0.39 to 0.78) and a 55% reduction of TVR (hazard ratio 0.45, 95% confidence interval 0.29 to 0.70). This result was consistent across most subgroups tested. Similar rates of death and MI were observed in the 2 treatment groups.ConclusionsIn this large real-world population, SES improved 1-year clinical results as compared to PES.

Full Text
View/download PDF

45. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)

Author

Eugenio Prati, Carlo Andrea Pivato, Bernhard Reimers, Alessandro Beneduce, Stefania Falcone, Cosmo Godino, Stefano De Martini, Valeria Magni, Antonio Colombo, Adele Pierri, Matteo Montorfano, David Rutigliano, Carlo Briguori, Maurizio Tespilli, Alfonso Ielasi, Franco Fabbiocchi, Rosario Parisi, Angelo Anzuini, Giuseppe Ferrante, Alberto Cappelletti, Nicola Locuratolo, Mauro Chiarito, Alberto Benassi, Giulia Perfetti, Antonio L. Bartorelli, Alberto Margonato, Godino, Cosmo, Beneduce, Alessandro, Ferrante, Giuseppe, Ielasi, Alfonso, Pivato, Andrea Carlo, Chiarito, Mauro, Cappelletti, Alberto, Perfetti, Giulia, Magni, Valeria, Prati, Eugenio, Falcone, Stefania, Pierri, Adele, De Martini, Stefano, Montorfano, Matteo, Parisi, Rosario, Rutigliano, David, Locuratolo, Nicola, Anzuini, Angelo, Tespilli, Maurizio, Margonato, Alberto, Benassi, Alberto, Briguori, Carlo, Fabbiocchi, Franco, Reimers, Bernhard, Bartorelli, Antonio, and Colombo, Antonio

Subjects
Male, Time Factors, Stent thrombosi, medicine.medical_treatment, 030204 cardiovascular system & hematology, Percutaneous coronary intervention, 0302 clinical medicine, Retrospective Studie, Biodegradable polymer sirolimus-eluting stent, Absorbable Implants, Drug-Eluting Stent, Clinical endpoint, High-risk patient, Medicine, Sirolimu, Registries, 030212 general & internal medicine, education.field_of_study, Drug-Eluting Stents, Middle Aged, Anti-Bacterial Agents, Death, Heart Disease, Treatment Outcome, Italy, Population Surveillance, Complex lesion, Female, Cardiology and Cardiovascular Medicine, Human, medicine.medical_specialty, Time Factor, Heart Diseases, Population, Subgroup analysis, Follow-Up Studie, 03 medical and health sciences, Absorbable Implant, Internal medicine, Anti-Bacterial Agent, Humans, education, Aged, Retrospective Studies, Sirolimus, business.industry, Stent, Retrospective cohort study, Clinical trial, Conventional PCI, business, Follow-Up Studies
Abstract

Background: This studywas designed to confirmin a large population of unselected patients the promising results of Ultimaster (R) biodegradable polymer sirolimus-eluting stent (BP-SES) already shown in previous trial.Methods: ULISSE is an observational, multicenter, national registry evaluating all patients undergoing PCI with the Ultimaster (R) BP-SES. Incidence of 1-year TLF (cardiac death or target vessel MI or clinically indicated TLR) was the primary endpoint. Pre-specified subgroup analysis was performed for diabetic patients and for those with lesion longer than 25 mm, bifurcation and CTO lesions.Results: 1660 patients were enrolled in 9 Italian cardiology centers, 82% weremales, mean age of 68 +/- 10 years, and 29% were diabetics. Overall 2422 lesions were treated, 65% type B2/C lesions, 7% CTOs, 17% bifurcations and 38% long lesions. The incidence of 1-year TLF was 5%, with 3.2% of clinically indicated TLR. TLF occurred in 8% of the patientswith diabetes mellitus, and 7% in bifurcation, 6.7% in CTO and 6.2% in long lesions. Definite overall ST was 0.9%, and 1.2% in patients treated for type B2/C lesions. Multivariate logistic regression analysis identified stenting on unprotected LMT (OR = 4.80), stenting on ISR lesion (OR = 3.19) and need for rotational atherectomy (OR = 6.24) as the strongest independent predictors of TLF.Conclusions: The results of this national all-comers registry show that the Ultimaster (R) BP-SES real-world performance was comparable with that observed in the clinical trial, with low rate of primary endpoint and TLR. Long term follow-up will be necessary to prove the theoretical advantage of the BP-SES over time. (c) 2018 Elsevier B.V. All rights reserved.

Published
2018

46. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients needing short dual antiplatelet therapy. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)

Author

David Rutigliano, Carlo Briguori, Bernhard Reimers, Valeria Magni, Alberto Benassi, Nicola Locuratolo, Giuseppe Ferrante, Giulia Perfetti, Carlo Andrea Pivato, Antonio L. Bartorelli, Alberto Margonato, Maurizio Tespili, Mauro Chiarito, Stefania Falcone, Alessandro Beneduce, Adele Pierri, Stefano De Martini, Angelo Anzuini, Alfonso Ielasi, Antonio Colombo, Cosmo Godino, Franco Fabbiocchi, Rosario Parisi, Alberto Cappelletti, Matteo Montorfano, Eugenio Prati, Godino, Cosmo, Beneduce, Alessandro, Ferrante, Giuseppe, Ielasi, Alfonso, Pivato, Carlo Andrea, Chiarito, Mauro, Cappelletti, Alberto, Perfetti, Giulia, Magni, Valeria, Prati, Eugenio, Falcone, Stefania, Pierri, Adele, De Martini, Stefano, Montorfano, Matteo, Parisi, Rosario, Rutigliano, David, Locuratolo, Nicola, Anzuini, Angelo, Tespili, Maurizio, Margonato, Alberto, Benassi, Alberto, Briguori, Carlo, Fabbiocchi, Franco, Reimers, Bernhard, Bartorelli, Antonio, and Colombo, Antonio

Subjects
medicine.medical_specialty, animal structures, Time Factors, Stent thrombosi, Polymers, medicine.medical_treatment, Thrombogenicity, 030204 cardiovascular system & hematology, Percutaneous coronary intervention, 03 medical and health sciences, 0302 clinical medicine, Biodegradable polymer sirolimus-eluting stent, Absorbable Implants, Medicine, Humans, In patient, 030212 general & internal medicine, Registries, Acute Coronary Syndrome, Target lesion revascularization, Aged, Retrospective Studies, Aged, 80 and over, Sirolimus, business.industry, Stent, Drug-Eluting Stents, Middle Aged, Discontinuation, Surgery, Treatment Outcome, Italy, Dual antiplatelet therapy, Conventional PCI, High bleeding risk, Cardiology and Cardiovascular Medicine, business, Immunosuppressive Agents, Platelet Aggregation Inhibitors, medicine.drug, Follow-Up Studies
Abstract

Background This study aimed to evaluate real-world clinical outcome of patients needing short dual antiplatelet therapy (S-DAPT) following PCI with Ultimaster® thin-strut, biodegradable polymer sirolimus-eluting stent (BP-SES), which was supposed to induce faster stent endothelialization and reduce device thrombogenicity. Methods In this sub-group analysis of patients enrolled in the ULISSE registry, two groups were identified: 1) patients discharged with S-DAPT (≤3-month) due to high bleeding risk or need for urgent major non-cardiac surgery and 2) patients discharged with recommended DAPT (R-DAPT) duration (≥6-month). The primary ischemic-safety and bleeding-safety endpoints were TLF (composite of cardiac-death, target vessel MI, and clinically driven target lesion revascularization), and BARC major bleedings (≥type-3a) at 1-year follow-up. To account for events occurring before DAPT discontinuation we performed 3-month landmark analysis. Results 82 patients (5%) were discharged with ≤3-month DAPT (57 ± 27 days), and 1558 patients (94%) were discharged with ≥6-month DAPT (318 ± 75 days). No significant differences between S-DAPT and R-DAPT group were observed in TLF at 1-year (7.9% vs. 4.6%). The rate of BARC major bleeding resulted significantly higher in S-DAPT group (3.9% vs. 0.3%; p = 0.001), with the majority of bleeding events occurring within 3 months. The landmark analysis showed no significant differences in BARC major bleedings between groups (1.4% vs. 0.3%; p = 0.142). Conclusions As compared to those treated with R-DAPT (≥6-month), patients needing -S-DAPT (≤3-month) after PCI with Ultimaster® BP-SES had similar rates of 1-year TLF and BARC major bleedings following early DAPT discontinuation.

Published
2019

47. Update of the position document of the Italian Society of Interventional Cardiology (SICI-GISE) on the minimum requirements for hospitals and operators performing procedures of a transcatheter implantation of aortic valve prostheses

Author

Tarantini, G., Esposito, G., Musumeci, G., Fraccaro, C., Franzone, A., Castiglioni, B., La Manna, A., Limbruno, U., Marchese, A., Mauro, C., Rigattieri, S., Tarantino, F., Gandolfo, C., Santoro, G., Violini, R., Airoldi, F., Albiero, R., Balbi, M., Baralis, G., Bartorelli, A.L., Bedogni, F., Benassi, A., Berni, A., Bonzani, G., Bortone, A.S., Braito, G., Briguori, C., Brscic, E., Calabrò, P., Calchera, I., Bigazzi, M.C., Caprioglio, F., Castriota, F., Cernetti, C., Cicala, C., Cioffi, P., Colombo, A., Colombo, V., Contegiacomo, G., Cremonesi, A., D'Amico, M., De Benedictis, M., De Leo, A., Di Biasi, M., Di Girolamo, D., Di Lorenzo, E., Di Mario, C., Dominici, M., Ettori, F., Ferrario, M., Fioranelli, M., Fischetti, D., Gabrielli, G., Giordano, A., Giudice, P., Greco, C., Indolfi, C., Leonzi, O., Lettieri, C., Loi, B., Maddestra, N., Marchionni, N., Marrozzini, C., Medda, M., Missiroli, B., Luigi, M., Oreglia, J.A., Palmieri, C., Pantaleo, P., Paparoni, S.R., Parodi, G., Petronio, A.S., Piatti, L., Piccaluga, E., Pierli, C., Perkan, A., Pitì, A., Poli, A., Ramondo, A.B., Reale, M.A., Reimers, B., Ribichini, F.L., Rosso, R., Saccà, S., Sacra, C., Santarelli, A., Sardella, G., Satullo, G., Scalise, F., Siviglia, M., Spedicato, L., Stabile, A., Tamburino, C., Tesorio, T.N.M., Tolaro, S., Tomai, F., Trani, C., Valenti, R., Valsecchi, O., Valva, G., Varbella, F., Vigna, C., Vignali, L., Berti, S., Tarantini, Giuseppe, Esposito, Giovanni, Musumeci, Giuseppe, Fraccaro, Chiara, Franzone, Anna, Castiglioni, Battistina, La Manna, Alessio, Limbruno, Ugo, Marchese, Alfredo, Mauro, Ciro, Rigattieri, Stefano, Tarantino, Fabio, Gandolfo, Caterina, Santoro, Gennaro, Violini, Roberto, Airoldi, Flavio, Albiero, Remo, Balbi, Manrico, Baralis, Giorgio, Bartorelli, Antonio Luca, Bedogni, Francesco, Benassi, Alberto, Berni, Andrea, Bonzani, Giulio, Bortone, Alessandro Santo, Braito, Giuseppe, Briguori, Carlo, Brscic, Elvi, Calabrò, Paolo, Calchera, Ivan, Cappelli Bigazzi, Maurizio, Caprioglio, Francesco, Castriota, Fausto, Cernetti, Carlo, Cicala, Cinzia, Cioffi, Paolo, Colombo, Antonio, Colombo, Virgilio, Contegiacomo, Gaetano, Cremonesi, Alberto, D'Amico, Maurizio, De Benedictis, Mauro, De Leo, Alessandro, Di Biasi, Maurizio, Di Girolamo, Domenico, Di Lorenzo, Emilio, Di Mario, Carlo, Dominici, Marcello, Ettori, Federica, Ferrario, Maurizio, Fioranelli, Massimo, Fischetti, Dionigi, Gabrielli, Gabriele, Giordano, Arturo, Giudice, Pietro, Greco, Cesare, Indolfi, Ciro, Leonzi, Ornella, Lettieri, Corrado, Loi, Bruno, Maddestra, Nicola, Marchionni, Niccolò, Marrozzini, Cinzia, Medda, Massimo, Missiroli, Bindo, Luigi, My, Oreglia, Jacopo Andrea, Palmieri, Cataldo, Pantaleo, Paolo, Paparoni, Saro Roberto, Parodi, Guido, Petronio, Anna Sonia, Piatti, Luigi, Piccaluga, Emanuela, Pierli, Carlo, Perkan, Andrea, Pitì, Antonino, Poli, Arnaldo, Ramondo, Angelo Bruno, Reale, Maurizio Alessandro, Reimers, Bernhard, Ribichini, Flavio Luciano, Rosso, Roberta, Saccà, Salvatore, Sacra, Cosimo, Santarelli, Andrea, Sardella, Gennaro, Satullo, Gaetano, Scalise, Filippo, Siviglia, Massimo, Spedicato, Leonardo, Stabile, Amerigo, Tamburino, Corrado, Tesorio, Tullio Nicola Maria, Tolaro, Salvatore, Tomai, Fabrizio, Trani, Carlo, Valenti, Renato, Valsecchi, Orazio, Valva, Giuseppe, Varbella, Ferdinando, Vigna, Carlo, Vignali, Luigi, and Berti, Sergio

Subjects
Transcatheter aortic valve implantation, Institutions, Operators, Requirements, Training, Cardiology and Cardiovascular Medicine, Requirement, Institution, Operator, Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Abstract

Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis and has become the standard of care for inoperable patients and the preferred therapy for those at increased surgical risk with peculiar clinical and anatomic features. Technology advances, growing experience and accumulating data prompted the update of the 2011 Italian Society of Interventional Cardiology (SICI-GISE) position paper on institutional and operator requirements to perform TAVI. The main objective of this document is to provide a guidance to assess the potential of institutions and operators to initiate and maintain an efficient TAVI program. Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis and has become the standard of care for inoperable patients and the preferred therapy for those at increased surgical risk with peculiar clinical and anatomic features. Technology advances, growing experience and accumulating data prompted the update of the 2011 Italian Society of Interventional Cardiology (SICI-GISE) position paper on institutional and operator requirements to perform TAVI. The main objective of this document is to provide a guidance to assess the potential of institutions and operators to initiate and maintain an efficient TAVI program.

Published
2018

48. [SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention].

Author

Guarini P, Saia F, Sidiropulos M, Silverio A, Dellegrottaglie S, Scatteia A, De Stefano F, Tedeschi C, Dalla Vecchia LA, Cappelletti AM, Regazzoli D, Benassi A, Donatelli F, America R, Nosso G, Capranzano P, Oliva A, Piccolo R, Testa L, Attisano T, Battistina C, Contarini M, De Marco F, Fineschi M, Menozzi A, Musto C, Stefanini G, Tarantini G, Caiazza F, and Esposito G

Subjects
Humans, Stroke Volume, Follow-Up Studies, Consensus, Ventricular Function, Left, Treatment Outcome, Acute Coronary Syndrome diagnosis, Percutaneous Coronary Intervention
Abstract

In the last decades, advances in percutaneous coronary intervention (PCI) strategies have significantly reduced the risk of procedural complications and in-hospital mortality of patients with acute coronary syndromes (ACS), thus increasing the population of stable post-ACS patients. This novel epidemiological scenario emphasizes the importance of implementing secondary preventive and follow-up strategies. The follow-up of patients after ACS or elective PCI should be based on common pathways and on the close collaboration between hospital cardiologists and primary care physicians. However, the follow-up strategies of these patients are still poorly standardized. This SICI-GISE/SICOA consensus document was conceived as a proposal for the long-term management of post-ACS or post-PCI patients based on their individual residual risk of cardiovascular adverse events. We defined five patient risk classes and five follow-up strategies including medical visits and examinations according to a specific time schedule. We also provided a short guidance for the selection of the appropriate imaging technique for the assessment of left ventricular ejection fraction and of non-invasive anatomical or functional tests for the detection of obstructive coronary artery disease. Physical and pharmacological stress echocardiography was identified as the first-line imaging technique in most of cases, while cardiovascular magnetic resonance should be preferred when an accurate evaluation of left ventricular ejection fraction is needed. The standardization of the follow-up pathways of patients with a history of ACS or elective PCI, shared between hospital doctors and primary care physicians, could result in a more cost-effective use of resources and potentially improve patient's long-term outcome.

Published
2023
Full Text
View/download PDF

49. Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study-The ISNEP Study.

Author

De Stefano F, Benassi A, Cappelletti AM, Donatelli F, Regazzoli D, Tolaro S, Perego F, Silverio A, Scatteia A, Guarini P, Dellegrottaglie S, Mariani S, Pezzella E, Galasso G, Caiazza F, and On Behalf Of Isnep Investigators

Abstract

Background: Atrial fibrillation (AF) is the most common heart arrhythmia, and its prevalence increases with age. Oral Anticoagulant Therapy (OAT) with non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) is essential to avoid thromboembolic events in AF. However, this treatment is associated with a high risk of bleeding and low adherence in elderly patients. Aim: The aim was to evaluate the real-world use of OAT in a population of patients aged ≥80 years in twenty-three Italian centers and to investigate the tolerance of and patient satisfaction with this therapy. Methods: The ISNEP Study is a multicenter cross-sectional study enrolling patients with AF and aged ≥80 years and treated with either NOACs or VKAs. A written questionnaire was administered to each patient to evaluate the adherence to and patient satisfaction with this therapy. Results: The study included 641 patients with a mean age of 85 (82−87) years. The use of NOACs was reported in 93.0% of cases, with the remaining 7.0% treated with VKAs. A history of stroke events was reported in five (11.1%) and one (0.2%) patients in the VKA and NOAC groups, respectively. The rate of referred ecchymosis/epistaxis was significantly higher in the VKA group compared to the NOAC group (p < 0.001). Patients receiving NOACs reported a substantial improvement in their quality of life compared to the VKA group. Conclusions: A small, but not negligible, proportion of elderly AF patients is still treated with VKAs. Patients treated with NOAC have a higher level of satisfaction with the therapy and complete adherence.

Published
2022
Full Text
View/download PDF

50. [Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation].

Author

Tarantini G, Esposito G, Musumeci G, Fraccaro C, Franzone A, Castiglioni B, La Manna A, Limbruno U, Marchese A, Mauro C, Rigattieri S, Tarantino F, Gandolfo C, Santoro G, Violini R, Airoldi F, Albiero R, Balbi M, Baralis G, Bartorelli AL, Bedogni F, Benassi A, Berni A, Bonzani G, Bortone AS, Braito G, Briguori C, Brscic E, Calabrò P, Calchera I, Cappelli Bigazzi M, Caprioglio F, Castriota F, Cernetti C, Cicala C, Cioffi P, Colombo A, Colombo V, Contegiacomo G, Cremonesi A, D'Amico M, De Benedictis M, De Leo A, Di Biasi M, Di Girolamo D, Di Lorenzo E, Di Mario C, Dominici M, Ettori F, Ferrario M, Fioranelli M, Fischetti D, Gabrielli G, Giordano A, Giudice P, Greco C, Indolfi C, Leonzi O, Lettieri C, Loi B, Maddestra N, Marchionni N, Marrozzini C, Medda M, Missiroli B, My L, Oreglia JA, Palmieri C, Pantaleo P, Paparoni SR, Parodi G, Petronio AS, Piatti L, Piccaluga E, Pierli C, Perkan A, Pitì A, Poli A, Ramondo AB, Reale MA, Reimers B, Ribichini FL, Rosso R, Saccà S, Sacra C, Santarelli A, Sardella G, Satullo G, Scalise F, Siviglia M, Spedicato L, Stabile A, Tamburino C, Tesorio TNM, Tolaro S, Tomai F, Trani C, Valenti R, Valsecchi O, Valva G, Varbella F, Vigna C, Vignali L, and Berti S

Subjects
Aortic Valve Stenosis physiopathology, Biomedical Technology trends, Humans, Italy, Severity of Illness Index, Transcatheter Aortic Valve Replacement instrumentation, Aortic Valve Stenosis surgery, Program Development methods, Transcatheter Aortic Valve Replacement methods
Abstract

Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis and has become the standard of care for inoperable patients and the preferred therapy for those at increased surgical risk with peculiar clinical and anatomic features. Technology advances, growing experience and accumulating data prompted the update of the 2011 Italian Society of Interventional Cardiology (SICI-GISE) position paper on institutional and operator requirements to perform TAVI. The main objective of this document is to provide a guidance to assess the potential of institutions and operators to initiate and maintain an efficient TAVI program.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results